Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lexicon Pharmaceuticals, Inc. - Common Stock
(NQ:
LXRX
)
2.200
+0.200 (+10.00%)
Streaming Delayed Price
Updated: 9:39 AM EDT, May 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lexicon Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Lexicon Pharmaceuticals Q1 Earnings Call Highlights
↗
May 08, 2026
Lexicon Pharmaceuticals (NASDAQ:LXRX) executives highlighted progress across late-stage regulatory programs and efforts to bolster the company’s financial position during the company’s first-quarter...
Via
MarketBeat
Topics
Earnings
Lexicon Pharmaceuticals (NASDAQ:LXRX) Q1 2026 Results Show Revenue Beat and Narrowed Loss
↗
May 07, 2026
Via
Chartmill
Lexicon (LXRX) Q4 2025 Earnings Call Transcript
↗
March 05, 2026
Lexicon (LXRX) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) Beats Q4 Estimates and Strengthens Cash Runway
↗
March 05, 2026
Via
Chartmill
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Shows High-Growth Momentum with Strong Technical and Fundamental Trends
↗
January 24, 2026
Via
Chartmill
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
December 31, 2025
Via
Chartmill
Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
November 17, 2025
Via
Benzinga
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Q3 2025 Earnings Surpass Expectations, Fueling Pre-Market Rally
↗
November 06, 2025
Lexicon Pharmaceuticals (LXRX) Q3 2025 earnings crush estimates with a massive revenue beat, driven by its Novo Nordisk partnership. The stock rose on the strong results and promising pipeline...
Via
Chartmill
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
September 29, 2025
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1...
Via
Benzinga
Topics
Stocks
Lexicon (LXRX) Q2 Revenue Soars 1,706%
↗
August 06, 2025
Via
The Motley Fool
Topics
Intellectual Property
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Q2 2025 Earnings: Revenue Soars 482% Above Estimates, Stock Gains 9.5%
↗
August 06, 2025
Lexicon Pharmaceuticals (LXRX) reports strong Q2 2025 earnings with $28.9M revenue, beating estimates by 482%. Stock rises 9.5% on profit surprise and pipeline progress.
Via
Chartmill
A Preview Of Lexicon Pharmaceuticals's Earnings
↗
May 12, 2025
Via
Benzinga
Top 2 Health Care Stocks That May Crash This Month
↗
April 25, 2025
Via
Benzinga
Curious about the most active stocks on Monday?
↗
March 31, 2025
Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today.
Via
Chartmill
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst
↗
March 31, 2025
U.S. stock futures fell on Monday after three consecutive days of decline on Friday. Futures of benchmark indices were lower in premarket.
Via
Benzinga
While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%
↗
March 31, 2025
As uncertainties surrounding trade policies, fresh recession fears, and persistent inflation kept the markets on tenterhooks throughout the past week, a handful of small-caps defied the odds by posting...
Via
Benzinga
Topics
Economy
Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session.
↗
March 28, 2025
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Friday's session: most active stocks
↗
March 28, 2025
Curious about the most active stocks on Friday? Find out which stocks are dominating the market action!
Via
Chartmill
Top movers in Friday's session
↗
March 28, 2025
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via
Chartmill
What 6 Analyst Ratings Have To Say About Lexicon Pharmaceuticals
↗
March 28, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 28, 2025
Via
Benzinga
Traders are paying attention to the gapping stocks in Friday's session.
↗
March 28, 2025
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Top movers in Friday's pre-market session
↗
March 28, 2025
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1
↗
March 28, 2025
The company is looking for drugs it can add to Wegovy to improve the amount of weight lost.
Via
Investor's Business Daily
Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected
↗
March 28, 2025
Via
Benzinga
Topics
Economy
Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
↗
March 28, 2025
Lexicon Pharmaceuticals granted Novo Nordisk exclusive rights to develop LX9851, an oral obesity drug, with potential milestone payments of up to $1 billion.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 28, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
